Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
Published in: | RMD Open |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Text |
Language: | English |
Published: |
BMJ Publishing Group
2018
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269640/ http://www.ncbi.nlm.nih.gov/pubmed/30564452 https://doi.org/10.1136/rmdopen-2018-000752 |
Description not available. |